Robert Long CV
Download Here!
Linkedin: www.linkedin.com/in/boblongceo
Phone: +1 (801) 318 9200
Email: long@glycocalyx.com
Professional Summary:
Robert (Bob) Long is a seasoned executive and innovator in the field of medical research, focusing on the endothelial glycocalyx and its role in glycocalyx and microvascular health. As a key leader and founder of several companies, including the Glycocalyx Research Institute and MicroVascular Health Solutions, Bob has contributed significantly to advancing research and clinical applications related to glycocalyx and microvascular health. His leadership in developing and commercializing GlycoCheck, a medical device for assessing glycocalyx and microvascular health, has been instrumental in early disease detection and vascular research.
In addition to his work with medical devices, Bob has played a pivotal role in the development of several groundbreaking nutraceuticals, including Arterosil, Endocalyx Pro, ReVasca, and ReNeu. Among these, ReVasca is a proprietary anti-aging supplement designed to support the restoration and protection of the endothelial glycocalyx, promote vascular health, and enhance overall glycocalyx and microvascular health. This product reflects Bob’s dedication to creating innovative solutions that improve human health and longevity.
Key Roles:
-
Founding Member – Genesis Health Science
Oct 2024 – Present
As a founding member of Genesis Health Science, Bob is contributing to its mission of advancing human health through cutting-edge technologies, nutraceuticals, and medical solutions. The organization focuses on adding complementary devices and products to establish itself as a leader in both regenerative and traditional medical spaces. This includes the development and commercialization of the GlycoCheck system and the establishment of the Glycocalyx Research Institute, furthering research and education on the endothelial glycocalyx's vital role in glycocalyx and microvascular health. -
CEO/President/Co-Founder – Glycocalyx Research Institute/GlycoCheck
Jun 2012 – Oct 2024 (12 years 5 months)
Co-founded the Glycocalyx Research Institute, specializing in education, training, and research on the endothelial glycocalyx and glycocalyx and microvascular health. Under Bob’s leadership: - Led the introduction of over 200 GlycoCheck units in more than 140 academic research hospitals worldwide.
- These partnerships have resulted in the publication of over 120 peer-reviewed papers in major journals, highlighting GlycoCheck’s application across a broad range of medical conditions and diseases.
- Developed GlycoCheck™, a clinically validated medical device for monitoring glycocalyx and microvascular health, as well as proprietary anti-aging supplements such as ReVasca™.
-
CEO/President/Founder – MicroVascular Health Solutions/GlycoCheck
Jun 2012 – Oct 2024 (12 years 5 months)
Led MicroVascular Health Solutions, which focused on supporting the health of the endothelial glycocalyx and distributing the GlycoCheck system worldwide. The company aimed to improve human glycocalyx and microvascular health through innovative technology and education. -
CEO & Founder – Vascular Health Sciences
Jul 2009 – Feb 2014 (4 years 8 months)
Founded Vascular Health Sciences, dedicated to advancing awareness and care of the endothelial glycocalyx. Bob guided the company's strategic direction, focusing on developing products to support glycocalyx and microvascular health. -
Vice President of Sales – Vantage Controls
Oct 2004 – Dec 2008 (4 years 3 months)
Played a key role in expanding the company’s sales network, increasing gross sales by over 280%, and assisting in the company's sale to Legrand. -
Managing Director – Northwestern Mutual
Mar 1980 – May 2004 (24 years 3 months) - President of the Managing Directors Association from 2002 to 2003, representing the interests of 350 agencies in their contracts, compensation, and all development programs.
- Achieved Top of the Table status in the Million Dollar Round Table in his last year before retiring, a testament to his exceptional performance in financial planning and sales.
- Managed Northwestern Mutual’s Top College Internship Program for 23 years, which was recognized as the Top Internship in America by the Princeton Review.
- Led a successful financial planning agency, building and training a team of 24 representatives. Under his management, the agency consistently performed in the top seven percent nationwide.
Education:
Brigham Young University – Business Management, Business Administration and Management, General
Activities: Rugby, Symphonic Band, Jazz Band
Languages:
- English: Native or bilingual proficiency
- Danish: Elementary proficiency
Recent Projects:
-
Development of GlycoCheck Software Upgrade
Role: Project Leader
Duration: 2023 - 2024
Achievements: - Spearheaded the development and launch of the GlycoCheck Software Upgrade, featuring enhanced algorithms, faster measurement modes, and a streamlined user interface.
- Conducted system upgrades, including camera calibration, ensuring optimal system performance for users worldwide.
- Introduced a pricing structure with unlimited patient testing, eliminating the per-test fee and making the upgrade cost-effective for healthcare providers.
-
Expansion of Glycocalyx Research
Role: Strategic Advisor and Co-Developer
Duration: Ongoing
Achievements: - Played a pivotal role in increasing the number of hospitals and research centers studying the endothelial glycocalyx from 3 to over 140.
- Collaborated on research cited in over 16,600 academic papers, contributing to global awareness of glycocalyx and microvascular health.
-
ReVasca Capsule Relaunch
Role: Operations and Distribution Leader
Duration: 2024
Achievements: - Managed the relaunch of ReVasca capsules, ensuring availability and streamlined distribution for pre-order customers and subscribers of the ship-and-save program.
- Coordinated production timelines and customer communication for a seamless restock experience.
-
Creation of a New Category in Medicine
Role: Visionary and Advocate
Duration: Ongoing
Achievements: - Co-led initiatives to establish a new category of medicine focused on glycocalyx and microvascular health restoration.
- Developed educational materials and programs to train practitioners on the significance of glycocalyx and microvascular health in disease prevention.